Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 75 Mcg (0.075 Mg), 10 Tablets (10 X 1) Unit Dose Blisters Per Carton

Recall Summary Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets 75 mcg in 10-tablet unit dose blisters nationwide because the tablets contain less active ingredient than they should (subpotent). This medication is used to treat thyroid conditions and requires consistent dosing to work properly. The recall affects patients who received this product across all U.S. states.

Recalling firm

Major Pharmaceuticals

Product

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-07-13

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/f228b471-ee24-4cc6-b9f3-78e7067b8796